Salmonella: Immune responses and vaccines

Veterinary Journal

Volumn 161, Issue 2, 2001, Pages 132-164

  Mastroeni, Pietro ^a   Chabalgoity, J A ^b   Dunstan, S J ^c   Maskell, D J ^a   Dougan, G ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Universidad de la Republica Instituto de Higiene   (Uruguay)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Immunity; Infection; Salmonella; Vaccines; Veterinary

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; CYTOKINE; DNA VACCINE; INACTIVATED VACCINE; LIVE VACCINE;

ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; BACTERIAL IMMUNITY; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CYTOKINE PRODUCTION; GENE MUTATION; HOST RESISTANCE; IMMUNE RESPONSE; NONHUMAN; PATHOGENESIS; REVIEW; SALMONELLA; SEROCONVERSION; VACCINATION;

ANIMALIA; BACTERIA (MICROORGANISMS); EUKARYOTA; RODENTIA; SALMONELLA;

EID: 0034965277     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1053/tvjl.2000.0502     Document Type: Review

References (370)

1. ACHARYA, I.L., LOWE, C.U., THAPA, R., GURUBACHARYA, V.L., SHRESTHA, M.B., CADOZ, M., SCHULZ, D., ARMAND, J., BRYLA, D.A. & TROLLFORS, B. (1987). Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. New England Journal of Medicine 317, 1101-4.
2. + cytotoxic T cells. Journal of Experimental Medicine 172, 1083-90.
3. AITKEN, M.M., JONES, P.W. & BROWN, G.T. (1982). Protection of cattle against experimentally induced salmonellosis by intradermal injection of heat-killed Salmonella dublin. Research in Veterinary Science 32, 368-73.
4. ALPUCHE-ARANDA, C.M., SWANSON, J.A., LOOMIS, W.P. & MILLER, S.I. (1992). Salmonella typhimurium activates virulence gene transcription within acidified macrophage phagosomes. Proceedings of the National Academy of Science USA 89, 10079-83.
5. ALTARE, F., LAMMAS, D., REVY, P., JOUANGUY, E., DOFFINGER, R., LAMHAMAMEDI, S., DRYSDALE, P., SCHEEL-TOELLNER, D., GIRDLESTONE, J., DARBYSHIRE, P., WADHWA, M., DOCKRELL, H., SALMON, M., FISCHER, A., DURANDY, A., CASANOVA, J.L. & KUMARARATNE, D.S. (1998). Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection. Journal of Clinical Investigation 102, 2035-40.
6. ANDERSON, J., SMITH, B.P. & ULRICH, J.T. (1991). Vaccination of calves with a modified bacterin or oil-in-water emulsion containing alkali-detoxified Salmonella typhimurium lipopolysaccharide. American Journal of Veterinary Research 52, 596-601.
7. ASCON, M.A., HONE, D.M., WALTERS, N. & PASCUAL, D.W. (1998). Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity. Infection and Immunity 66, 5470-6.
8. ATTRIDGE, S., HACKETT, J., MORONA, R. & WHYTE, P. (1988). Towards a live oral vaccine against enterotoxigenic Escherichia coli of swine. Vaccine 6, 387-9.
9. BAIREY, M.H. (1978). Immunization of calves against salmonellosis. Journal of the American Veterinary Medical Association 173, 610-3.
10. BARBOUR, E.K, FRERICHS, W.M., NABBUT, N.H., Poss, P.E. & BRINTON, M.K. (1993). Evaluation of bacterins containing three predominant phage types of Salmonella enteritidis for prevention of infection in egg-laying chickens. American Journal of Veterinary Research 54, 1306-9.
11. BARROW, P.A., BERCHIERI, A., JR. & AL-HADDAD, O. (1992). Serological response of chickens to infection with Salmonella gallinarum-S. pullorum detected by enzyme-linked immunosorbent assay. Avian Disease 36, 227-36.
12. BARROW, P.A., HASSAN, J.O., LOVELL, M.A. & BERCHIERI, A. (1990a). Vaccination of chickens with aroA and other mutants of Salmonella typhimurium and S. enteritidis. Research in Microbiology 141, 851-3.
13. BARROW, P.A., LOVELL, M.A. & BERCHIERI, A. (1990b). Immunisation of laying hens against Salmonella enteritidis with live attenuated vaccines. Veterinary Record 126, 241-2.
14. BARROW, P.A., LOVELL, M.A. & BERCHIERI, A. (1991). The use of two live attenuated vaccines to immunise egg-laying hens against Salmonella enteritidis phage type 4. Avian Pathology 20, 681-2.
15. BARRY, E.M., GOMEZ-DUARTE, O., CHATFIELD, S., RAPPUOLI, R., PIZZA, M., LOSONSKY, G., GALEN, J. & LEVINE, M.M. (1996). Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908. Infection and Immunity 64, 4172-81.
16. BELLANTI, J.A., ZELIGS, B.J., VETRO, S., PUNG, Y.H., LUCCIOLI, S., MALAVASIC, M.J., HOOKE, A.M., UBERTINI, T.R., VANNI, R. & NENCIONI, L. (1993). Studies of safety, infectivity and immunogenicity of a new temperature-sensitive (ts) 51-1 strain of Salmonella typhi as a new live oral typhoid fever vaccine candidate. Vaccine 11, 587-90.
17. BERCHIERI, A., JR. & BARROW, P.A. (1990). Further studies on the inhibition of colonization of the chicken alimentary tract with Salmonella typhimurium by pre-colonization with an avirulent mutant. Epidemiology and Infection 104, 427-41.
18. BLACK, R.E., LEVINE, M.M., CLEMENTS, M.L., LOSONSKY, G., HERRINGTON, D., BERMAN, S. & FORMAL, S.B. (1987). Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine. Journal of Infectious Disease 155, 1260-5.
19. BRADLEY, M.P., HINDS, L.A. & BIRD, P.H. (1997). A bait-delivered immunocontraceptive vaccine for the European red fox (Vulpes vulpes) by the year 2002? Reproduction, Fertility and Development 9, 111-6.
20. BRAYTON, K.A., VAN DER WALT, M., VOGEL, S.W. & ALLSOPP, B.A. (1998). A partially protective clone from Cowdria ruminantium identified by using a Salmonella vaccine delivery system. Annals of the New York Academy of Sciences 849, 247-52.
21. BRENNAN, F.R., OLIVER, J.J. & BAIRD, G.D. (1994). Differences in the immune responses of mice and sheep to an aromatic-dependent mutant of Salmonella typhimurium. Journal of Medical Microbiology 41, 20-8.
22. BRETT, S.J., DUNLOP, L., LIEW, F.Y. & TITE, J.P. (1993). Influence of the antigen delivery system on immunoglobulin isotype selection and cytokine production in response to influenza A nucleoprotein. Immunology 80, 306-12.
23. BROWN, A. & HORMAECHE, C.E. (1989). The antibody response to Salmonellae in mice and humans studied by immunoblots and ELISA. Microbial Pathogenesis 6, 445-54.
24. BROWN, A., HORMAECHE, C.E., DEMARCO DE HORMAECHE, R., WINTHER, M., DOUGAN, G., MASKELL, D.J., & STOCKER, B.A. (1987a). An attenuated aroA Salmonella typhimurium vaccine elicits humoral and cellular immunity to cloned β-galactosidase in mice. Journal of Infectious Diseases 155, 86-92.
25. BROWN, A., HORMAECHE, C.E., DEMARCO DE HORMAECHE, R., WINTHER, M., DOUGAN. G., MASKELL, D.J. & STOCKER, B.A. (1987b). An attenuated aroA Salmonella typhimurium vaccine elicits humoral and cellular immunity to cloned β-galactosidase in mice. Journal of Infectious Diseases 155, 86-92.
26. BUCHMEIER, N.A., LIPPS, C.J., SO, M.Y & HEFFRON, F. (1993). Recombination-deficient mutants of Salmonella typhimurium are avirulent and sensitive to the oxidative burst of macrophages. Molecular Microbiology 7, 933-6.
27. CANCELLIERI, V. & FARA, G.M. (1985). Demonstration of specific IgA in human feces after immunization with live Ty21a Salmonella typhi vaccine. Journal of Infectious Diseases 151, 482-4.
28. CAO, Y., WEN, Z. & LU, D. (1992). Construction of a recombinant oral vaccine against Salmonella typhi and Salmonella typhimurium. Infection and Immunity 60, 2823-7.
29. CARLIN, N.I., SVENSON, S.B. & LINDBERG, A.A. (1987). Role of monoclonal O-antigen antibody epitope specificity and isotype in protection against experimental mouse typhoid. Microbial Pathogenesis 2, 171-83.
30. CARRIER, M.J., CHATFIELD, S.N., DOUGAN, G., NOWICKA, U.T., O'CALLAGHAN, D., BEESLEY, J.E., MILANO, S., CILLARI, E. & LIEW, F. Y. (1992). Expression of human IL-1β in Salmonella typhimurium. A model system for the delivery of recombinant therapeutic proteins in vivo. Journal of Immunology 148, 1176-81.
31. CARTER, P.B. & COLLINS, F.M. (1974). The route of enteric infection in normal mice. Journal of Experimental Medicine 139, 1189-203.
32. CATIC, A., DIETRICH, G., GENTSCHEV, I., GOEBEL, W., KAUFMANN, S.H. & HESS, J. (1999). Introduction of protein or DNA delivered via recombinant Salmonella typhimurium into the major histocompatibility complex class I presentation pathway of macrophages. Microbes and Infection 1, 113-121.
33. CATMULL, J., WILSON, M.E., KIRCHHOFF, L.V., METWALI, A. & DONELSON, J.E. (1999). Induction of specific cell-mediated immunity in mice by oral immunization with Salmonella expressing Onchocerca volvulus glutathione S-transferase. Vaccine 17, 31-9.
34. CATTOZZO, E.M., STOCKER, B.A., RADAELLI, A., DE GIULI MORGHEN, C. & TOGNON, M. (1997). Expression and immunogenicity of V3 loop epitopes of HIV-1, isolates SC and WMJ2, inserted in Salmonella flagellin. Journal of Biotechnology 56, 191-203.
35. CHABALGOITY, J.A., KHAN, C.M., NASH, A.A. & HORMAECHE, C.E. (1996). A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection. Molecular Microbiology 19, 791-801.
36. CHABALGOITY, J.A. HARRISON, J.A., ESTEVES, A., DEMARCO DE HORMAECHE, R., EHRLICH, R., KHAN, C.M. & HORMAECHE, C. E. (1997). Expression and immunogenicity of an Echinococcus granulosus fatty acid-binding protein in live attenuated Salmonella vaccine strains. Infection and Immunity 65, 2402-12.
37. CHABALGOITY, J.A., MORENO, M., CAROL, H., DOUGAN, G. & HORMAECHE, C.E. (2000). A dog-adapted Salmonella Typhimurium strain as a basis for a live oral Echinococcus Granulosus vaccine. Vaccine 19, 460-69.
38. CHARBIT, A., MARTINEAU, P., RONCO, J., LECLERC, C., LO-MAN, R., MICHEL, V., O'CALLANGHAN, D. & HOFNUNG, M. (1993). Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in an attenuated aroA strain of Salmonella typhimurium upon genetic coupling to two Escherichia coli carrier proteins. Vaccine 11, 1221-8.
39. CHATFIELD, S.N., CHARLES, I.G., MAKOFF, A.J., OXER, M.D., DOUGAN, G., PICKARD, D., D. SLATER, D. & FAIRWEATHER, N.F. (1992c). Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Bio/Technology N Y 10, 888-92.
40. CHATFIELD, S.N., FAIRWEATHER, N., CHARLES, I., PICKARD, D., LEVINE, M., HONE. D., POSADA, M., STRUGNELL, R.A. & DOUGAN, G. (1992a). Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine. Vaccine 10, 53-60.
41. CHATFIELD, S.N., STRAHAN, K., PICKARD, D., CHARLES, I.G., HORMAECHE, C.E. & DOUGAN, G. (1992b). Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model. Microbial Pathogenesis 12, 145-51.
42. CIRILLO, D.M., VALDIVIA, R.H., MONACK, D.M. & FALKOW, S. (1998). Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival. Molecular Microbiology 30, 175-88.
43. CLARKE, R.C. & GYLES, C.L. (1986). Galactose epimeraseless mutants of Salmonella typhimurium as live vaccines for calves. Canadian Journal of Veterinary Research 50, 165-73.
44. COLLINS, F.M. (1974). Vaccines and cell-mediated immunity. Bacteriological Reviews 38, 371-402.
45. CONLAN, J.W. & NORTH, R.J. (1992). Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes. Infection and Immunity 60, 5164-71.
46. COOKSON, B.T. & BEVAN, M.J. (1997). Identification of a natural T cell epitope presented by Salmonella-infected macrophages and recognized by T cells from orally immunized mice. Journal of Immunology 158, 4310-9.
47. COOPER, G.L. & THORNS, C.J. (1996). Evaluation of SEF14 fimbrial dot blot and flagellar western blot tests as indicators of Salmonella enteritidis infection in chickens. Veterinary Record 138, 149-53.
48. COOPER, G.L., NICHOLAS, R.A., CULLEN, G.A. & HORMAECHE, C.E. (1990). Vaccination of chickens with a Salmonella enteritidis aroA live oral Salmonella vaccine. Microbial Pathogenesis 9, 255-65.
49. COOPER, G.L., VENABLES, L.M., NICHOLAS, R.A., CULLEN, G.A. & HORMAECHE, C.E. (1992). Vaccination of chickens with chicken-derived Salmonella enteritidis phage type 4 aroA live oral Salmonella vaccines. Vaccine 10, 247-54.
50. COOPER, G.L., VENABLES, L.M., NICHOLAS, R.A., CULLEN, G.A. & HORMAECHE, C.E. (1993). Further studies of the application of live Salmonella enteritidis aroA vaccines in chickens. Veterinary Record 133, 31-6.
51. COOPER, G.L., VENABLES, L.M., WOODWARD, M.J. & HORMAECHE, C.E. (1994a). Invasiveness and persistence of Salmonella enteritidis, Salmonella typhimurium, and a genetically defined S. enteritidis aroA strain in young chickens. Infection and Immunity 62, 4739-46.
52. COOPER, G.L., VENABLES, L.M., WOODWARD, M.J. & HORMAECHE, C.E. (1994b). Vaccination of chickens with strain CVL30, a genetically defined Salmonella enteritidis aroA live oral vaccine candidate. Infection and Immunity 62, 4747-54.
53. CORTHESY-THEULAZ, I.E., HOPKINS, S., BACHMANN, D., SALDINGER, P.F., PORTA, N., HAAS, R., ZHENG-XIN, Y., MEYER, T., BOUZOURENE, H., BLUM, A.L. & KRAEHENBUHL, L.P. (1998). Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits. Infection and Immunity 66, 581-6.
54. COULSON, N.M., FULOP, M. & TITBALL, R.W. (1994a). Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge. Vaccine 12, 1395-401.
55. COULSON, N.M., FULOP, M. & TITBALL, R.W. (1994b). Effect of different plasmids on colonization of mouse tissues by the aromatic amino acid dependent Salmonella typhimurium SL 3261. Microbial Pathogenesis 16, 305-11.
56. COVONE, M.G., BROCCHI, M., PALLA, E., DIAS DA SILVEIRA, W., RAPPUOLI, R. & GALEOTTI, C.L. (1998). Levels of expression and immunogenicity of attenuated Salmonella enterica scrovar typhimurium strains expressing Escherichia coli mutant heat-labile enterotoxin. Infection and Immunity 66, 224-31.
57. CRYZ, S.J., FURER, E., BARON, L.S., NOON, K.F., RUBIN, F.A. & KOPECKO, D.J. (1989). Construction and characterization of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a. Infection and Immunity 57, 3863-8.
58. CRYZ, S.J., JR., VANPRAPAR, N., THISYAKORN, U., OLANRATMANEE, T., LOSONSKY, G., LEVINE, M.M. & CHEARSKUL, S. (1993). Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children. Infection and Immunity 61, 1149-51.
59. CURTISS, R.D. & KELLY, S.M. (1987). Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infection and Immunity 55, 3035-43.
60. CURTISS, R.D., KELLY, S.M., GULIG, P.A. & NAKAYAMA, K. (1989). Selective delivery of antigens by recombinant bacteria. Current Topics in Microbiology and Immunology 146, 35-49.
61. D'OLIVEIRA, C., FEENSTRA, A., Vos, H., OSTERHAUS, A.D., SHIELS, B.R., CORNELISSEN, A.W. & JONGEJAN, F. (1997). Induction of protective immunity to Theileria annulata using two major merozoite surface antigens presented by different delivery systems. Vaccine 15, 1796-804.
62. DARJI, A., GUZMAN, C.A., GERSTEL, B., WACHHOLZ, P., TIMMIS, K. N., WEHLAND, J., CHAKRABORTY, T. & WEISS, S. (1997). Oral somatic transgene vaccination using attenuated S. typhimurium. Cell 91, 765-75.
63. DAVIES, R. & KOTLARSKI, I. (1976). A role for antibody in the expression of cellular immunity to Salmonella typhimurium C5. Australian Journal of Experimental Biology and Medical Science 54, 207-19.
64. DE GROOTE, M.A., TESTERMAN, T., Xu, Y., STAUFFER, G. & FANG, F.C. (1996). Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. Science 272, 414-7.
65. DE GROOTE, M.A., OCHSNER, U.A., SHILOH, M.U., Nathan, C., MCCORD, J.M., DINAUER, M.C., LIBBY, S. J., VAZQUEZ-TORRES, A., XU, Y. & FANG, F.C. (1997). Periplasmic Superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. Proceedings of the National Academy of Science USA 94, 13997-4001.
66. DE JONG, R., ALTARE, F., HAAGEN, I.A., ELFERINK, D.G., BOER, T., VAN BREDA VRIESMAN, P.J., KABEL, P.J., DRAAISMA, J.M., VAN DISSEL, J.T., KROON, F.P., CASANOVA, J.L. & OTTENHOFF, T.H. (1998). Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280, 1435-8.
67. DEIWICK, J., NIKOLAUS, T., ERDOGAN, S. & HENSEL, M. (1999). Environmental regulation of Salmonella pathogenicity island 2 gene expression. Molecular Microbiology 31, 1759-73.
68. DENICH, K, BORLIN, P., O'HANLEY, P.D., HOWARD, M. & HEATH, A.W. (1993). Expression of the murine interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium: persistence and immune response in BALB/c mice and susceptibility to macrophage killing. Infection and Immunity 61, 4818-27.
69. DING, H.F., NAKONECZNA, I. & HSU, H.S. (1990). Protective immunity induced in mice by detoxified Salmonella lipopolysaccharide. Journal of Medical Microbiology 31, 95-102.
70. DORMAN, C.J., CHATFIELD, S., HIGGINS, C.F., HAYWARD, C. & DOUGAN, G. (1989). Characterization of porin and ompR mutants of a virulent strain of Salmonella typhimurium: ompR mutants are attenuated in vivo. Infection and Immunity 57, 2136-40.
71. DOUCET, F. & BERNARD, S. (1997). In vitro cellular responses from sheep draining lymph node cells after subcutaneous inoculation with Salmonella abortusovis. Veterinary Research 28, 165-78.
72. DOUGAN, G., CHATFIELD, S., PICKARD, D., BESTER, J., O'CALLAGHAN, D. & MASKELL, D. (1988). Construction and characterization of vaccine strains of Salmonella harboring mutations in two different aro genes. Journal of Infectious Diseases 158, 1329-35.
73. DUNLAP, N.E., BENJAMIN, W.H., JR., MCCALL, R.D., JR., TILDEN, A.B. & BRILES, D.E. (1991). A 'safe-site' for Salmonella typhimurium is within splenic cells during the early phase of infection in mice. Microbial Pathogenesis 10, 297-310.
74. DUNNE, M., AL-RAMADI, B.K., BARTHOLD, S.W., FLAVELL, R.A. & FIKRIG, E. (1995). Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis. Infection and Immunity 63, 1611-4.
75. DUNSTAN, S.J., RAMSAY, A.J. & STRUGNELL, R.A. (1996). Studies of immunity and bacterial invasiveness in mice given a recombinant Salmonella vector encoding murine interleukin-6. Infection and Immunity 64, 2730-6.
76. DUSEK, D.M., PROGULSKE-FOX, A. & BROWN, T.A. (1994). Systemic and mucosal immune responses in mice orally immunized with avirulent Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin. Infection and Immunity 62, 1652-7.
77. EISENSTEIN, T.K., KILLAR, L.M. & SULTZER, B.M. (1984). Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine- and serum-mediated protection. Journal of Infectious Diseases 150, 425-35.
78. EMOTO, M., DANBARA, H. & YOSHIKAI, Y. (1992). Induction of γ/δ T cells in murine salmonellosis by an avirulent but not by a virulent strain of Salmonella choleraesuis. Journal of Experimental Medicine 176, 363-72.
79. ERVIN, S.E., SMALL, P., JR. & GULIG, P.A. (1993). Use of incompatible plasmids to control expression of antigen by Salmonella typhimurium and analysis of immunogenicity in mice. Microbial Pathogenesis 15, 93-101.
80. EVEREST, P., FRANKEL, G., LI, J., LUND, P., CHATFIELD, S. & DOUGAN, G. (1995). Expression of LacZ from the htrA, nirB and groE promoters in a Salmonella vaccine strain: influence of growth in mammalian cells. FEMS Microbiology Letters 126, 97-101.
81. EVEREST, P., ALLEN, J., PAPAKONSTANTINOPOULOU, A., MASTROENI, P., ROBERTS, M. & DOUGAN, G. (1997). Salmonella typhimurium infections in mice deficient in interleukin-4 production: role of IL-4 in infection-associated pathology. Journal of Immunology 159, 1820-7.
82. EVEREST, P., ROBERTS, M. & DOUGAN, G. (1998). Susceptibility to Salmonella typhimurium infection and effectiveness of vaccination in mice deficient in the tumor necrosis factor α p55 receptor. Infection and Immunity 66, 3355-64.
83. FAGAN, P.K., DJORDJEVIC, S.P., CHIN, J., EAMENS, G.J. & WALKER, M.J. (1997). Oral immunization of mice with attenuated Salmonella typhimurium aroA expressing a recombinant Mycoplasma hyponeumoniae antigen (NrdF). Infection and Immunity 65, 2502-7.
84. FIELDS, P.I., SWANSON, R.V., HAIDARIS, G.G. & HEFFRON, F. (1986). Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proceedings of the National Academy of Science USA 83, 5189-93.
85. FLYNN, J.L., WEISS, W.R., NORRIS, K.A., SEIFERT, H.S., KUMAR, S. & So, M. (1990). Generation of a cytotoxic T-lymphocyte response using a Salmonella antigen-delivery system. Molecular Microbiology 4, 2111-8.
86. FORREST, B.D., LABROOY, J.T., BEYER, L., DEARLOVE, C.E. & SHEARMAN, D.J. (1991). The human humoral immune response to Salmonella typhi Ty21a. Journal of Infectious Diseases 163, 336-45.
87. GALAN, J.E. & CURTISS, R.D. (1989). Virulence and vaccine potential of phoP mutants of Salmonella typhimurium. Microbial Pathogenesis 6, 433-43.
88. GALAN, J.E., NAKAYAMA, K. & CURTISS, R.D. (1990). Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene 94, 29-35.
89. GALDIERO, M., DE MARTINO, L., MARCATILI A., Nuzzo, I., VITIELLO, M. & CIPOLLARO DE L'ERO, G. (1998). Th1 and Th2 cell involvement in immune response to Salmonella typhimurium porins. Immunology 94, 5-13.
90. GALEN, J.E., NAIR, J., WANG, J.Y., WASSERMAN, S.S., TANNER, M.K., SZTEIN, M.B. & LEVINE, M.M. (1999). Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. Infection and Immunity 67, 6424-33.
91. GAST, R.K., STONE, H.D., HOLT, P.S. & BEARD, C.W. (1992). Evaluation of the efficacy of an oil-emulsion bacterin for protecting chickens against Salmonella enteritidis. Avian Disease 36, 992-9.
92. GAST, R.K., STONE, H.D. & HOLT, P.S. (1993). Evaluation of the efficacy of oil-emulsion bacterins for reducing fecal shedding of Salmonella enteritidis by laying hens. Avian Disease 37, 1085-91.
93. GENTSCHEV, I., SOKOLOVIC, Z., KOHLER, S., KROHNE, G.F., HOF, H., WAGNER, J. & GOEBEL, W. (1992). Identification of p60 antibodies in human sera and presentation of this listerial antigen on the surface of attenuated Salmonellae by the HlyB-HlyD secretion system. Infection and Immunity 60, 5091-8.
94. GENTSCHEV, I., GLASER, I., GOEBEL, W., MCKEEVER, D.J., MUSOKE, A. & HEUSSLER, V.T. (1998). Delivery of the p67 sporozoite antigen of Theileria parva by using recombinant Salmonella dublin: secretion of the product enhances specific antibody responses in cattle. Infection and Immunity 66, 2060-4.
95. GERMANIER, R. & FURER, E. (1971). Immunity in experimental salmonellosis. II. Basis for the avirulence and protective capacity of gal E mutants of Salmonella typhimurium. Infection and Immunity 4, 663-73.
96. GHERARDI, M.M., GARCIA, V.E., BRIZZIO, V., SORDELLI, D.O. & CERQUETTI, M.C. (1993a). Differential persistence, immunogenicity and protective capacity of temperature-sensitive mutants of Salmonella enteritidis after oral or intragastric administration to mice. FEMS Immunology Medical Microbiology 7, 161-8.
97. GHERARDI, M.M., GARCIA, V.E., SORDELLI, D.O. & CERQUETTI, M.C. (1993b). Protective capacity of a temperature-sensitive mutant of Salmonella enteritidis after oral and intragastric inoculation in a murine model. Vaccine 11, 19-24.
98. GILMAN, R.H., HORNICK, R.B., WOODARD, W.E., DUPONT, H.L., SNYDER, M.J., LEVINE, M.M. & LIBONATI, J.P. (1977). Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine. Journal of Infectious Diseases 136, 717-23.
99. GOHIN, I., OLIVIER, M., LANTIER, I., PEPIN, M. & LANTIER, F. (1997). Analysis of the immune response in sheep efferent lymph during Salmonella abortusovis infection. Veterinary Immunology and Immunopathology 60, 111-30.
100. GOMEZ-DUARTE, O.G., GALEN, J., CHATFIELD, S.N., RAPPUOLI, R., EIDELS, L. & LEVINE, M.M. (1995). Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphtheria toxin in Salmonella typhi CVD 908 vaccine strain. Vaccine 13, 1596-602.
101. GOMEZ-DUARTE, O.G., LUCAS, B., YAN, Z.X., PANTHEL, K., HAAS, R. & MEYER, T.F. (1998). Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B. Vaccine 16, 460-71.
102. GOMEZ-DUARTE, O.G., BUMANN, D. & MEYER, T.F. (1999). The attenuated Salmonella vaccine approach for the control of Helicobacter pylori-related diseases. Vaccine 17, 1667-73.
103. GOTTSTEIN, B., MULLER, N., CRYZ, S., JR., VOGEL, M., TANNER, I. & SEEBECK, T. (1990a). Humoral and cellular immune response in mice and dogs induced by a recombinant Echinococcus multilocularis antigen produced by a Salmonella typhimurium vaccine strain. Parasite Immunology 12, 163-74.
104. GOTTSTEIN, B., MULLER, N., CRYZ, S., JR., VOGEL, M., TANNER, I. & SEEBECK, T. (1990b). Humoral and cellular immune response in mice and dogs induced by a recombinant Echinococcus multilocularis antigen produced by a Salmonella typhimurium vaccine strain. Parasite Immunology 12, 163-74.
105. GRAY, J.T., STABEL, T.J. & FEDORKA-CRAY, P.J. (1996). Effect of dose on the immune response and persistence of Salmonella choleraesuis infection in swine. American Journal of Veterinary Research 57, 313-9.
106. GRIFFIN, H.G. & BARROW, P.A. (1993). Construction of an aroA mutant of Salmonella serotype Gallinarum: its effectiveness in immunization against experimental fowl typhoid. Vaccine 11, 457-62.
107. GROISMAN, E.A. & SAIER, M.H., JR. (1990). Salmonella virulence: new clues to intramacrophage survival. Trends in Biochemical Sciences 15, 30-3.
108. GROISMAN, E.A., HEFFRON, F. & SOLOMON, F. (1992a). Molecular genetic analysis of the Escherichia coli phoP locus. Journal of Bacteriology 174, 486-91.
109. GROISMAN, E.A., PARRA-LOPEZ, C., SALCEDO, M., LIPPS, C.J. & HEFFRON, F. (1992b). Resistance to host antimicrobial peptides is necessary for Salmonella virulence. Proceedings of the National Academy of Science USA 89, 11939-43.
110. + T cells in acquired immunity and granuloma formation. Microbial Pathogenesis 14, 45-55.
111. GUZMAN, C.A., BROWNLIE, R.M., KADURUGAMUWA, J., WALKER, M.J. & TIMMIS, K.N. (1991). Antibody responses in the lungs of mice following oral immunization with Salmonella typhimurium aroA and invasive Escherichia coli strains expressing the filamentous hemagglutinin of Bordetella pertussis. Infection and Immunity 59, 4391-7.
112. HADDAD, D., LILJEQVIST, S., KUMAR, S., HANSSON, M., STAHL, S., PERLMANN, H., PERLMANN, P. & BERZINS, K. (1995). Surface display compared to periplasmic expression of a malarial antigen in Salmonella typhimurium and its implications for immunogenicity. FEMS Immunology Medical Microbiology 12, 175-86.
113. HAHN, H.P., HESS, C., GABELSBERGER, J., DOMDEY, H. & VON SPECHT, B.U. (1998). A Salmonella typhimurium strain genetically engineered to secrete effectively a bioactive human interleukin (hIL)-6 via the Escherichia coli hemolysin secretion apparatus. FEMS Immunology Medical Microbiology 20, 111-9.
114. HARRISON, J.A., VILLARREAL-RAMOS, B., MASTROENI, P., DEMARCO DE HORMAECHE, R. & HORMAECHE, C.E. (1997). Correlates of protection induced by live AroSalmonella typhimurium vaccines in the murine typhoid model. Immunology 90, 618-25.
115. HASSAN, J.O. & CURTISS, R.D. (1990). Control of colonization by virulent Salmonella typhimurium by oral immunization of chickens with avirulent Δcya Δcrp S. typhimurium [published erratum appears in Res Microbiol 1991 Jan; 142(1):109]. Research in Microbiology 141, 839-50.
116. HASSAN, J.O. & CURTISS, R., 3RD. (1994). Development and evaluation of an experimental vaccination program using a live avirulent Salmonella typhimurium strain to protect immunized chickens against challenge with homologous and heterologous Salmonella serotypes. Infection and Immunity 62, 5519-27.
117. HASSAN, J.O. & CURTISS, R., 3RD. (1997). Efficacy of a live avirulent Salmonella typhimurium vaccine in preventing colonization and invasion of laying hens by Salmonella typhimurium and Salmonella enteritidis. Avian Disease 41, 783-91.
118. HASSAN, J.O., MOCKETT, A.P., CATTY, D. & BARROW, P.A. (1991). Infection and reinfection of chickens with Salmonella typhimurium: bacteriology and immune responses. Avian Disease 35, 809-19.
119. HAYES, L.J., CONLAN, J.W., EVERSON, J.S., WARD, M.E. & CLARKE, I.N. (1991). Chlamydia trachomatis major outer membrane protein epitopes expressed as fusions with LamB in an attenuated aro A strain of Salmonella typhimurium; their application as potential immunogens. Journal of General Microbiology 137, 1557-64.
120. HEITHOFF, D.M., SINSHEIMER, R.L., LOW, D.A., MAHAN, M.J. (1999). An essential role for DNA adenine methylation in bacterial virulence. Science 284, 967-70.
121. HENSEL, M., SHEA, J.E., RAUPACH, B., MONACK, D., FALKOW, S., GLEESON, C., KUBO, T. & HOLDEN, D.W. (1997). Functional analysis of ssaJ and the ssaK/U operon, 13 genes encoding components of the type III secretion apparatus of Salmonella Pathogenicity Island 2. Molecular Microbiology 24, 155-67.
122. HESS, J., GENTSCHEV, I., MIKO, D., WELZEL, M., LADEL, C., GOEBEL, W. & KAUFMANN, S. II. (1996a). Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proceedings of the National Academy of Science USA 93, 1458-63.
123. + TCR-α/β cells and IFN-γ in bacterial clearance independent of intracellular location. Journal of Immunology 156, 3321-6.
124. HESS, J., DIETRICH, G., GENTSCHEV, I, MIKO, D., GOEBEL, W. & KAUFMANN, S.H. (1997). Protection against murine listeriosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the naturally somatic antigen Superoxide dismutase. Infection and Immunity 65, 1286-92.
125. HEUSSLER, V.T., TARACHA, E.L., MUSOKE, A., DUCHATEAU, L. & MCKEEVER, D.J. (1998). Immunisation with live attenuated Salmonella dublin expressing a sporozoite protein confers partial protection against Theileria parva. Vaccine 16, 834-41.
126. HIROSE, K., NISHIMURA, H., MATSUGUCHI, T. & YOSHIKAI, Y. (1999). Endogenous IL-15 might be responsible for early protection by natural killer cells against infection with an avirulent strain of Salmonella choleraesuis in mice. Journal of Leukocyte Biology 66, 382-90.
127. HOCHABEL, J.F. & KELLER, K.F. (1977). Protective effects of passively transferred immune T- or B-lymphocytes in mice infected with Salmonella typhimurium. Journal of Infectious Diseases 135, 813-23.
128. HOHMANN, E.L., OLETTA, C.A., LOOMIS, W.P. & MILLER, S.I. (1995). Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity. Proceedings of the National Academy of Science USA 92, 2904-8.
129. HOHMANN, E.L., OLETTA, C.A., KILLEEN, K.P. & MILLER, S.I. (1996a). phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. Journal of Infectious Diseases 173, 1408-14.
130. HOHMANN, E.L., OLETTA, C.A. & MILLER, S.I. (1996b). Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Vaccine 14, 19-24.
131. HOISETH, S.K. & STOCKER, B.A. (1981). Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291, 238-9.
132. HONE, D., MORONA, R., ATTRIBGE, S. & HACKETT, J. (1987). Construction of defined galE mutants of Salmonella for use as vaccines. Journal of Infectious Diseases 156, 167-74.
133. HONE, D., ATTRIDGE, S., VAN-BEN-BOSCH, L. & HACKETT, J. (1988a). A chromosomal integration system for stabilization of heterologous genes in Salmonella based vaccine strains. Microbial Pathogenesis 5, 407-18.
134. HONE, D.M., ATTRIDGE, S.R., FORREST, B., MORONA, R., DANIELS, D., LABROOY, J.T., BARTHOLOMEUSZ, R.C., SHEARMAN, D.J. & HACKETT, J. (1988b). A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans. Infection and Immunity 56, 1326-33.
135. HOOKE, A.M., CERQUETTI, M.C., ZELIGS, B.J., WANG, Z., HOBERG, K. & BELLANTI, J.A. (1993). Genetically stable temperature-sensitive mutants of Salmonella typhi induce protection in mice. Vaccine 11, 1386-9.
136. HOPKINS, S.A. & KRAEHENBUHL, J.P. (1997). Dendritic cells of the murine Peyer's patches colocalize with Salmonella typhimurium avirulent mutants in the subepithelial dome. Advances in Experimental Medicine and Biology 417, 105-9.
137. HOPKINS, S., KRAEHENBUHL, J.P., SCHODEL, F., POTTS, A., PETERSON, D., DE GRANDI, P. & NARDELLI-HAEFLIGER, D. (1995). A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infection and Immunity 63, 3279-86.
138. HORMAECHE, C.E. (1979a). Genetics of natural resistance to Salmonellae in mice. Immunology 37, 319-27.
139. HORMAECHE, C.E. (1979b). The natural resistance of radiation chimeras to S. typhimurium C5. Immunology 37, 329-32.
140. HORMAECHE, C.E. (1979c). Natural resistance to Salmonella typhimurium in different inbred mouse strains. Immunology 37, 311-8.
141. HORMAECHE, C.E. (1990). Dead Salmonellae or their endotoxin accelerate the early course of a Salmonella infection in mice. Microbial Pathogenesis 9, 213-8.
142. HORMAECHE, C.E., FAHRENKROG, M.C., PETTIFOR, R.A. & BROCK, J. (1981a). Acquired immunity to Salmonella typhimurium and delayed (footpad) hypersensitivity in BALB/c mice. Immunology 43, 547-54.
143. HORMAECHE, C.E., PETTIFOR, R.A. & BROCK, J. (1981b). The fate of temperature-sensitive Salmonella mutants in vivo in naturally resistant and susceptible mice. Immunology 42, 569-76.
144. HORMAECHE, C.E., HARRINGTON, K.A. & JOYSEY, H.S. (1985). Natural resistance to Salmonellae in mice: control by genes within the major histocompatibility complex. Journal of Infectious Diseases 152, 1050-6.
145. HORMAECHE, C.E., MASTROENI, P., ARENA, A., UDDIN, J. & JOYSEY, H.S. (1990). T cells do not mediate the initial suppression of a Salmonella infection in the RES. Immunology 70, 247-50.
146. HORMAECHE, C.E., KHAN, C.M.A., MASTROENI, P., VILLAREAL, B., DOUGAN, G. & CHATFIELD, S.N. (1995). In "Molecular and clinical aspects of vaccine development." (D. Ala'Aldeen, and Hormaeche, C.E., ed.), pp. 119-153. John Wiley & Sons, Ltd., London.
147. HORMAECHE, C.E., JOYSEY, H.S., DESILVA, L., IZHAR, M. & STOCKER, B.A. (1991). Immunity conferred by Aro Salmonella live vaccines. Microbial Pathogenesis 10, 149-58.
148. HORMAECHE, C.E., MASTROENI, P., HARRISON, J.A., DEMARCO DE HORMAECHE, R., SVENSON, S. & STOCKER, B.A. (1996). Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen. Vaccine 14, 251-9.
149. HSU, H.S. (1989). Pathogenesis and immunity in murine salmonellosis. Microbiological Reviews 53, 390-409.
150. HU, J., BUMSTEAD, N., BARROW, P., SEBASTIANI, G., OLIEN, L., MORGAN, K. & MALO, D. (1997). Resistance to salmonellosis in the chicken is linked to NRAMP1 and TNC. Genome Research 7, 693-704.
151. IANARO, A., XU, D., O'DONNELL, C.A., DI-ROSA, M. & LIEW, F.Y. (1995). Expression of TGF-β in attenuated Salmonella typhimurium: oral administration leads to the reduction of inflammation, IL-2 and IFN-γ, but enhancement of IL-10, in carrageenin-induced oedema in mice. Immunology 84, 8-15.
152. IZHAR, M., DESILVA, L., JOYSEY, H.S. & HORMAECHE, C.E. (1990). Moderate immunodeficiency does not increase susceptibility to Salmonella typhimurium aroA live vaccines in mice. Infection and Immunity 58, 2258-61.
153. JAGUSZTYN-KRYNICKA, E.K., CLARK-CURTISS, J.E. & CURTISS, R.D. (1993). Escherichia coli heat-labile toxin subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: importance of the linker for antigenicity and biological activities of the hybrid proteins. Infection and Immunity 61, 1004-15.
154. JOHNSON, K., CHARLES, I., DOUGAN, G., PICKARD, D., O'GAORA, P., COSTA, G., ALI, T., MILLER, I. & HORMAECHE, C. (1991). The role of a stress-response protein in Salmonella typhimurium virulence. Molecular Microbiology 5, 401-7.
155. JOHNSON, K.S., CHARLES, I.G., DOUGAN, G., MILLER, I.A., PICKARD, D., O'GOARA, P., COSTA, G., ALI, T. & HORMAECHE, C.E. (1990). The role of a stress-response protein in bacterial virulence. Research in Microbiology 141, 823-5.
156. JONES, P.W., DOUGAN, G., HAYWARD, C., MACKENSIE, N., COLLINS, P. & CHATFIELD, S.N. (1991). Oral vaccination of calves against experimental salmonellosis using a double aro mutant of Salmonella typhimurium. Vaccine 9, 29-34.
157. KAGAYA, K, WATANABE, K. & FUKAZAWA, Y. (1989). Capacity of recombinant γ interferon to activate macrophages for Salmonella-killing activity. Infection and Immunity 57, 609-15.
158. KANTELE, A., ARVILOMMI, H. & JOKINEN, I. (1986). Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi. Journal of Infectious Diseases 153, 1126-31.
159. KANTELE, A., ARVILOMMI, H., KANTELE, J.M., RINTALA, L. & MAKELA, P.H. (1991). Comparison of the human immune response to live oral, killed oral or killed parenteral Salmonella typhi TY21A vaccines. Microbial Pathogenesis 10, 117-26.
160. KANTELE, A., HAKKINEN, M., MOLDOVEANU, Z., LU, A, SAVILATHI, E., ALVAREZ, R.D., MICHALEK, S. & MESTECKY, J. (1998). Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans. Infection and Immunity 66, 5630-5.
161. KANTELE, A., WESTERHOLM, M., KANTELE, J.M., MAKELA, P.H. & SAVILAHTI, E. (1999). Homing potentials of circulating antibody-secreting cells after administration of oral or parenteral protein or polysaccharide vaccine in humans. Vaccine 17, 229-36.
162. KAREM, K.L., CHATFIELD, S., KUKLIN, N. & ROUSE, B.T. (1995). Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice. Infection and Immunity 63, 4557-63.
163. KAREM, K.L., BOWEN, J., KUKLIN, N. & ROUSE, B.T. (1997). Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens. Journal of General Virology 78, 427-34.
164. KAUFMANN, S.H. (1993). Immunity to intracellular bacteria. Annual Review of Immunology 11, 129-63.
165. KENNEDY, M.J., YANCEY, R.J., JR., SANCHEZ, M.S., RZEPKOWSKI, R.A., KELLY, S.M. & CURTISS, R., 3RD. (1999). Attenuation and immunogenicity of Δcya Δcrp derivatives of Salmonella choleraesuis in pigs. Infection and Immunity 67, 4628-36.
166. KHAN, C.M., VILLARREAL-RAMOS, B., PIERCE, R.J., DEMARCODE-HORMAECHE, R., MCNEILL, H., ALI, T., CHATFIELD, S., CAPRON, A., DOUGAN, G. & H, C. E. (1994a). Construction, expression, and immunogenicity of multiple tandem copies of the Schistosoma mansoni peptide 115-131 of the P28 glutathione S-transferase expressed as C-terminal fusions to tetanus toxin fragment C in a live aro-attenuated vaccine strain of Salmonella. Journal of Immunology 153, 5634-42.
167. KHAN, C.M., VILLARREAL-RAMOS, B., PIERCE, R.J., RIVEAU, G., DEMARCO-DE-HORMAECHE, R., MCNEILL, H., ALI, T., FAIRWEATHER, N., CHATFIELD, S., CAPRON, A. & ET, A. (1994b). Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. Proceedings of the National Academy of Science USA 91, 11261-5.
168. KHAN, S.A., EVEREST, P., SERVOS, S., FOXWELL N., ZAHRINGER, U., BRADE, H., RIETSCHEL, E.T., DOUGAN, G., CHARLES, I.G. & MASKELL D.J. (1998). A lethal role for lipid A in Salmonella infections. Molecular Microbiology 29, 571-9.
169. KILLAR, L.M. & EISENSTEIN, T.K. (1984). Differences in delayed-type hypersensitivity responses in various mouse strains in the C3H lineage infected with Salmonella typhimurium, strain SL3235. Journal of Immunology 133, 1190-6.
170. KILLAR, L.M. & EISENSTEIN, T.K. (1985). Immunity to Salmonella typhimurium infection in C3H/HeJ and C3H/HeNCrlBR mice: studies with an aromatic-dependent live S. typhimurium strain as a vaccine. Infection and Immunity 47, 605-12.
171. KILLAR, L.M. & EISENSTEIN, T.K. (1986). Delayed-type hypersensitivity and immunity to Salmonella typhimurium. Infection and Immunity 52, 504-8.
172. KINCY-CAIN, T., CLEMENTS, J.D. & BOST, K.L. (1996). Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin. Infection and Immunity 64, 1437-40.
173. KLUGMAN, K.P., KOORNHOF, H.J., ROBBINS, J.B. & LE CAM, N.N. (1996). Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine 14, 435-8.
174. KONADU, E.Y., LIN, F.Y., HO, V.A., THUY, N.T., VAN BAY, P., THANH, T.C., KHIEM, H.B., TRACH, D.D., KARPAS, A.B., LI, J., BRYLA, D.A., ROBBINS, J.B. & SZU, S.C. (2000). Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam [In Process Citation]. Infection and Immunity 68, 1529-34.
175. KOSSACZKA, Z., LIN, F.Y., HO, V.A., THUY, N.T., VAN BAY, P., THANH, T.C., Khiem, H.B., TRACH, D.D., KARPAS, A., HUNT, S., BRYLA, D.A., SCHNEERSON, R., ROBBINS, J.B. & SZU, S.C. (1999). Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam. Infection and Immunity 67, 5806-10.
176. KOVACSOVICSBANKOWSKI, M., CLARK, K., BENACERREF, B. & ROCK, K.L. (1993). Efficient major histocompatibility complex class-I presentation of exogenous antigen upon phagocytosis by macrophages. Proceedings of the National Academy of Science USA 90, 4942-4946.
177. KUUSI, N., NURMINEN, M., SAXEN, H., VALTONEN, M. & MAKELA, P.H. (1979). Immunization with major outer membrane proteins in experimental salmonellosis of mice. Infection and Immunity 25, 857-62.
178. LEARY, S.E.C., GRIFFIN, K.F., GARMORY, H.S., WILLIAMSON, E.D. & TITBALL, R.W. (1997). Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague. Microbial Pathogenesis 23, 167-79.
179. LEVINE, M.M., DUPONT, H.L., HORNICK, R.B., SNYDER, M.J., WOODWARD, W., GILMAN, R.H. & LIBONATI, J.P. (1976). Attenuated, streptomycin-dependent Salmonella typhi oral vaccine: potential deleterious effects of lyophilization. Journal of Infectious Diseases 133, 424-9.
180. LEVINE, M.M., HERRINGTON, D., MURPHY, J.R., MORRIS, J.G., LOSONSKY, G., TALL, B., LINDBERG, A.A., SVENSON, S., BAQAR, S. & EDWARDS, M.F. (1987). Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. Journal of Clinical Investigation 79, 888-902.
181. LEVINE, M.M., FERRECCIO, C., BLACK, R.E., TACKET, C.O. & GERMANIER, R. (1989). Progress in vaccines against typhoid fever. Review of Infectious Diseases 11 Suppl 3, S552-67.
182. LIANG-TAKASAKI, C.J., SAXEN, H., MAKELA, P.H. & LEIVE, L. (1983). Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of Salmonellae. Infection and Immunity 41, 563-9.
183. LINDBERG, A.A. & ROBERTSSON, J.A. (1983). Salmonella typhimurium infection in calves: cell-mediated and humoral immune reactions before and after challenge with live virulent bacteria in calves given live or inactivated vaccines. Infection and Immunity 41, 751-7.
184. LINDBERG, A.A., SEGALL, T., WEINTRAUB, A. & STOCKER, B.A. (1993). Antibody response and protection against challenge in mice vaccinated intraperitoneally with a live aroA O4-O9 hybrid Salmonella dublin strain. Infection and Immunity 61, 1211-21.
185. LISSNER, C.R., SWANSON, R.N. & O'BRIEN, A.D. (1983). Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro. Journal of Immunology 131, 3006-13.
186. + T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules. Journal of Immunology 162, 5398-406.
187. LONDONO, L.P., CHATFIELD, S., TINDLE, R.W., HERD, K., GAO, X.M., FRAZER, I. & DOUGAN, G. (1996). Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen. Vaccine 14, 545-52.
188. LUMSDEN, J.S. & WILKIE, B.N. (1992). Immune response of pigs to parenteral vaccination with an aromatic-dependent mutant of Salmonella typhimurium. Canadian Journal of Veterinary Research 56, 296-302.
189. LUMSDEN, J.S., WILKIE, B.N. & CLARKE, R.C. (1991). Resistance to fecal shedding of Salmonellae in pigs and chickens vaccinated with an aromatic-dependent mutant of Salmonella typhimurium. American Journal of Veterinary Research 52, 1784-7.
190. MACFARLANE, A.S., SCHWACHA, M.G. & EISENSTEIN, T.K. (1999). In vivo blockage of nitric oxide with aminoguanidine inhibits immunosuppression induced by an attenuated strain of Salmonella typhimurium, potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleen. Infection and Immunity 67, 891-8.
191. MASKELL, D.J., HORMAECHE, C.E., HARRINGTON, K.A., JOYSEY, H.S. & LIEW, F.Y. (1987a). The initial suppression of bacterial growth in a Salmonella infection is mediated by a localized rather than a systemic response. Microbial Pathogenesis 2, 295-305.
192. MASKELL, D.J., SWEENEY, K.J., O'CALLAGHAN, D., HORMAECHE, C.E., LIEW, F.Y. & DOUGAN, G. (1987b). Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems. Microbial Pathogenesis 2, 211-21.
193. MASTROENI, P., ARENA, A., COSTA, G.B., LIBERTO, M.C., BONINA, L. & HORMAECHE, C.E. (1991). Serum TNF α in mouse typhoid and enhancement of a Salmonella infection by anti-TNF α antibodies. Microbial Pathogenesis 11, 33-8.
194. MASTROENI, P., VILLARREAL-RAMOS, B. & HORMAECHE, C.E. (1993b). Adoptive transfer of immunity to oral challenge with virulent Salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells. Infection and Immunity 61, 3981-4.
195. MASTROENI, P., VILLARREAL-RAMOS, B. & HORMAECHE, C.E. (1993c). Effect of late administration of anti-TNF α antibodies on a Salmonella infection in the mouse model. Microbial Pathogenesis 14, 473-80.
196. MASTROENI, P., HARRISON, J.A., CHABALGOITY, J.A. & HORMAECHE, C.E. (1996). Effect of interleukin 12 neutralization on host resistance and γ interferon production in mouse typhoid. Infection and Immunity 64, 189-96.
197. MASTROENI, P., HARRISON, J.A., ROBINSON, J.H. CLARE, S., KHAN, S., MASKELL, D.J., DOUGAN, G. & HORMAECHE, C. E. (1998). Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent Salmonellae in BALB/c mice: role of γ interferon and macrophage activation. Infection and Immunity 66, 4767-76.
198. MASTROENI, P., CLARE, S., KHAN, S., HARRISON, J.A., HORMAECHE, C.E., OKAMURA, H., KURIMOTA, M. & DOUGAN, G. (1999). Interleukin 18 contributes to host resistance and γ interferon production in mice infected with virulent Salmonella typhimurium. Infection and Immunity 67, 478-83.
199. (-/-) (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Infection and Immunity 68, 46-53.
200. MASTROENI, P., VAZAVEZ-TORRES, A., FANG, F. et al. (2000b). Antimicrobial actions of the nadph phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects of microbial proliferation and host survival in vivo. Journal of Experimental Medicine 192, 237-47.
201. MASTROENI, P., SKEPPER, J.N. & HORMAECHE, C.E. (1995). Effect of anti-tumor necrosis factor α antibodies on histopathology of primary Salmonella infections [published erratum appears in Infect Immun 1995 Dec;63(12):4966]. Infection and Immunity 63, 3674-82.
202. MASTROENI, P., VILLARREAL, B., DEMARCO DE HORMAECHE, R. & HORMAECHE, C.E. (1992a). Serum TNF α inhibitor in mouse typhoid. Microbial Pathogenesis 12, 343-9.
203. MASTROENI, P., VILLARREAL-RAMOS, B. & HORMAECHE, C.E. (1992b). Role of T cells, TNF α and IFN γ in recall of immunity to oral challenge with virulent Salmonellae in mice vaccinated with live attenuated aro- Salmonella vaccines. Microbial Pathogenesis 13, 477-91.
204. MASTROENI, P., VILLARREAL-RAMOS, B., DEMARCO dE HORMAECHE, R. & HORMAECHE, C.E. (1993a). Delayed (footpad) hypersensitivity and Arthus reactivity using protein-rich antigens and LPS in mice immunized with live attenuated aroA Salmonella vaccines. Microbial Pathogenesis 14, 369-79.
205. MATES, A., MACKESY, D., GRAYSON, G.G. & HINTON, N.A. (1981). Immune response in dog. 5 Hyperimmunization with Salmonella typhosa vaccine. Microbios 31, 113-24.
206. MATSUI, K. & ARAI, T. (1989). Protective immunity induced by porin in experimental mouse salmonellosis. Microbiology and Immunology 33, 699-708.
207. MCFARLAND, W.C. & STOCKER, B.A. (1987). Effect of different purine auxotrophic mutations on mouse-viulence of a Vi-positive strain of Salmonella dublin and of two strains of Salmonella typhimurium. Microbial Pathogenesis 3, 129-41.
208. + T cell responses during natural infection with Salmonella typhimurium. Journal of Immunology 164, 986-993.
209. MCSORLEY, S.J., XU, D. & LIEW, F.Y. (1997). Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters. Infection and Immunity 65, 171-8.
210. MEDINA, E., GUZMAN, C.A., STAENDNER, E.H., COLOMBO, M.P. & PAGLIA, P. (1999). Salmonella vaccine carrier strains: effective delivery system to trigger anti-tumor immunity by oral route. European Journal of Immunology 29, 693-9.
211. MEENAKSHI, M., BAKSHI, C.S., BUTCHAIAH, G., BANSAL, M.P., SIDDIQUI, M.Z. & SINGH, V.P. (1999). Adjuvanted outer membrane protein vaccine protects poultry against infection with Salmonella enteritidis. Veterinary Research Communication 23, 81-90.
212. METCALF, E. & O'BRIEN, A.D. (1981). Characterization of murine antibody response to Salmonella Typhimucium by a class-specific solid-phase radio immunoassay. Infection and Immunity 31, 33-41.
213. MEYER, H., BARROW, P.A. & PARDON, P. (1992). Salmonella immunisation in animals. Proceedings of the international symposium on Salmonella and salmonellosis. Ploifragan, France. Sept. 15-17, 1992, pp.345-74.
214. MILLER, S.I. (1991). PhoP/PhoQ: macrophage-specific modulators of Salmonella virulence? Molecular Microbiology 5, 2073-8.
215. MITOV, I., DENCHEV, V. & LINDE, K. (1992). Humoral and cell-mediated immunity in mice after immunization with live oral vaccines of Salmonella typhimurium: auxotrophic mutants with two attenuating markers. Vaccine 10, 61-6.
216. MITTRUCKER, H.W., RAUPACH, B., KOHLER, A. & KAUFMANN, S.H. (2000). Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection. Journal of Immunology 164, 1648-52.
217. MIXTER, P.F., CAMERINI, V., STONE, B.J., MILLER, V.L. & KRONENBERG, M. (1994). Mouse T lymphocytes that express a γ δ T-cell antigen receptor contribute to resistance to Salmonella infection in vivo. Infection and Immunity 62, 4618-21.
218. MIYAMOTO, T., KITAOKA, D., WITHANAGE, G.S., FUKATA, T., SASAI, K. & BABA, E. (1999). Evaluation of the efficacy of Salmonella enteritidis oil-emulsion bacterin in an intravaginal challenge model in hens. Avian Disease 43, 497-505.
219. MOLINA, N.C. & PARKER, C.D. (1990). Murine antibody response to oral infection with live aroA recombinant Salmonella dublin vaccine strains expressing filamentous hemagglutinin antigen from Bordetella pertussis. Infection and Immunity 58, 2523-8.
220. MORONA, R., MORONA, J.K., CONSIDINE, A. HACKETT, J.A., VAN-DEN-BOSCH, E., BEYER, E. & ATTRIDGE, S.R. (1994). Construction of K88- and K99-expressing clones of Salmonella typhimurium G30: immunogenicity following oral administration to pigs. Vaccine 12, 513-7.
221. MUIR, W.I., BRYDEN, W.L. & HUSBAND, A.J. (1998). Evaluation of the efficacy of intraperitoneal immunization in reducing Salmonella typhimurium infection in chickens. Poultry Science 77, 1874-83.
222. MUKKUR, T.K., MCDOWELL, G.H., STOCKER, B.A. & LASCELLES, A.K. (1987). Protection against experimental salmonellosis in mice and sheep by immunisation with aromatic-dependent Salmonella typhimurium. Journal of Medical Microbiology 24, 11-9.
223. MUKKUR, T.K., WALKER, K.H., JONES, D., WRONSKI, E. & LOVE, D.N. (1991). Immunizing efficacy of aromatic-dependent Salmonella dublin in mice and calves. Comparative Immunology, Microbiology and Infectious Diseases 14, 243-56.
224. MUKKUR, T.K., WALKER, K.H., BAKER, P. & JONES, D. (1995). Systemic and mucosal intestinal antibody response of sheep immunized with aromatic-dependent live or killed Salmonella typhimurium. Comparative Immunology, Microliology and Infections Diseases 18, 27-39.
225. MUOTIALA, A. (1992). Anti-IFN-γ-treated mice: a model for testing safety of live Salmonella vaccines. Vaccine 10, 243-6.
226. MUOTIALA, A. & MAKELA, P.H. (1990). The role of IFN-γ in murine Salmonella typhimurium infection. Microbial Pathogenesis 8, 135-41.
227. MUOTIALA, A. & MAKELA, P.H. (1993). Role of γ interferon in late stages of murine salmonellosis. Infection and Immunity 61, 4248-53.
228. MURPHY, J.R., BAQAR, S., MUNOZ, C., SCHLESINGER, L., FERRECCIO, C., LINDBERG, A.A., SVENSON, S., LOSONSKY, G., KOSTER, F. & LEVINE, M.M. (1987). Characteristics of humoral and cellular immunity to Salmonella typhi in residents of typhoid-endemic and typhoid-free regions. Journal of Infectious Diseases 156, 1005-9.
229. MURPHY, J.R., WASSERMAN, S.S., BAQAR, S., SCHLESINGER, L., FERRECCIO, C., LINDBERG, A.A. & LEVINE, M.M. (1989). Immunity to Salmonella typhi: considerations relevant to measurement of cellular immunity in typhoid-endemic regions. Clinical Experimental Immunology 75, 228-33.
230. + expression cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Bio/Technology 6, 693-697.
231. NARDELLI-HAEFLIGER, D., KRAEHENBUHL, J.P., CURTISS, R.R., SCHODEL, F., POTTS, A., KELLY, S. & DE GRANDI, P. (1996). Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain. Infection and Immunity 64, 5219-24.
232. NARDELLI-HAEFLIGER, D., RODEN, R.B., BENYACOUB, J., SAHLI, R., KRAEHENBUHL, J.P., SCHILLER, J.T., LACHAT, P., POOTS, A. & DE GRANDI, P. (1997). Human papillo-mavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice. Infection and Immunity 65, 3328-36.
233. + T cells and T-independent mechanisms in acquired resistance to Salmonella typhimurium infection. Journal of Immunology 145, 1265-9.
234. NAUCIEL, C. & ESPINASSE-MAES, F. (1992). Role of γ interferon and tumor necrosis factor a in resistance to Salmonella typhimurium infection. Infection and Immunity 60, 450-4.
235. NAUCIEL, C., RONCO, E., GUENET, J.L. & PLA, M. (1988). Role of H-2 and non-H-2 genes in control of bacterial clearance from the spleen in Salmonella typhimurium-infected mice. Infection and Immunity 56, 2407-11.
236. NAUCIEL, C., RONCO, E. & PLA, M. (1990). Influence of different regions of the H-2 complex on the rate of clearance of Salmonella typhimurium. Infection and Immunity 58, 573-4.
237. NAYAK, A.R., TINGE, S.A., TART, R.C., McdANIEL, L.S., BRILES, D.E. & CURTISS, R.R. (1998). A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae. Infection and Immunity 66, 3744-51.
238. NEWTON, S.M., JACOB, C.O. & STOCKER, B.A. (1989). Immune response to cholera toxin epitope inserted in Salmonella flagellin. Science 244, 70-2.
239. NEWTON, S.M., JOYS, T.M., ANDERSON, S.A., KENNEDY, R.C., HOVI, M.E. & STOCKER, B.A. (1995a). Expression and immunogenicity of an 18-residue epitope of HIV1 gp41 inserted in the flagellar protein of a Salmonella live vaccine. Research in Microbiology 146, 203-16.
240. NEWTON, S.M., KOTB, M., POIRIER, T.P., STOCKER, B.A. & BEACHEY, E.H. (1991). Expression and immunogenicity of a streptococcal M protein epitope inserted in Salmonella flagellin. Infection and Immunity 59, 2158-65.
241. NIELSEN, B., BAGGESEN, D., BAGER, F., HAUGEGAARD, J. & LIND, P. (1995). The serological response to Salmonella serovars typhimurium and infantis in experimentally infected pigs. The time course followed with an indirect anti-LPS ELISA and bacteriological examinations. Veterinary Microbiology 47, 205-18.
242. NISHIMURA, H., HIROMATSU, K., KOBAYASHI, N., GRABSTEIN, K.H., PAXTON, R., SUGAMURA, K., BLUESTONE, J.A. & YOSHIKAI, Y. (1996). IL-15 is a novel growth factor for murine γ δ T cells induced by Salmonella infection. Journal of Immunology 156, 663-9.
243. + γδ T cells are induced in mice by Salmonella infection. Journal of Immunology 162, 1573-81.
244. NNALUE, N.A. & STOCKER, B.A. (1986). Some galE mutants of Salmonella choleraesuis retain virulence. Infection and Immunity 54, 635-40.
245. O'BRIEN, A.D. & METCALF, E.S. (1982). Control of early Salmonella typhimurium growth in innately Salmonella-resistant mice does not require functional T lymphocytes. Journal of Immunology 129, 1349-51.
246. O'BRIEN, A.D., METCALF, E.S. & ROSENSTREICH, D.L. (1982). Defect in macrophage effector function confers Salmonella typhimurium susceptibility on C3H/HeJ mice. Cellular Immunology 67, 325-33.
247. O'BRIEN, A.D. & ROSENSTREICH, D.L. (1983). Genetic control of the susceptibility of C3HeB/FeJ mice to Salmonella typhimurium is regulated by a locus distinct from known Salmonella response genes. Journal of Immunology 131, 2613-5.
248. O'BRIEN, A.D., ROSENSTREICH, D.L., SCHER, I., CAMPBELL, G.H., MACDERMOTT, R.P. & FORMAL, S.B. (1980). Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. Journal of Immunology 124, 20-4.
249. O'BRIEN, A.D., SCHER, I., CAMPBELL, G.H., MACDERMOTT, R.P. & FORMAL, S.B. (1979a). Susceptibility of CBA/N mice to infection with Salmonella typhimurium: influence of the X-linked gene controlling B lymphocyte function. Journal of Immunology 123, 720-4.
250. O'BRIEN, A.D., SCHER, I. & FORMAL, S.B. (1979b). Effect of silica on the innate resistance of inbred mice to Salmonella typhimurium infection. Infection and Immunity 25, 513-20.
251. O'BRIEN, A.D., SCHER, I. & METCALF, E.S. (1981). Genetically conferred defect in anti-Salmonella antibody formation renders CBA/N mice innately susceptible to Salmonella typhimurium infection. Journal of Immunology 126, 1368-72.
252. O'BRIEN, A.D., TAYLOR, B.A. & ROSENSTREICH, D.L. (1984). Genetic control of natural resistance to Salmonella typhimurium in mice during the late phase of infection. Journal of Immunology 133, 3313-8.
253. O'CALLAGHAN, D., MASKELL, D., LIEW, F.Y., EASMON, C.S. & DOUGAN, G. (1988). Characterization of aromatic-and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice. Infection and Immunity 56, 419-23.
254. O'CALLAGHAN, D., MASKELL, D., TITE, J. & DOUGAN, G. (1990). Immune responses in BALB/c mice following immunization with aromatic compound or purine-dependent Salmonella typhimurium strains. Immunology 69, 184-9.
255. OGUNNIYI, A.D., MANNING, P.A. & KOTLARSKI, I. (1994). A Salmonella enteritidis 11RX pilin induces strong T-lymphocyte responses. Infection and Immunity 62, 5376-83.
256. OXER, M.D., BENTLY, C.M., DOYLE, J.G., PEAKMAN, T.C., CHARLES, I.G. & A.J., M. (1991). High level heterologous expression in E. coli using the anaerobically-activated nirB promoter. Nucleic Acids Research 19, 1889-1892.
257. OYSTON, P.C., WILLIAMSON, E.D., LEARY, S.E., ELEY, S.M., GRIFFIN, K.F. & TITBALL, R.W. (1995). Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague. Infection and Immunity 63, 563-8.
258. PAGLIA, P., MEDINA, E., ARIOLI, I., GUZMAN, C.A. & COLOMBO, M.P. (1998). Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood 92, 3172-6.
259. PASCUAL, D.W., HONE, D.M., HALL, S., VAN GINKEL, F.W., YAMAMOTO, M., WALTERS, N., FUJIHASHI, K., POWELL, R.J., WU, S., VANCOTT, J.L., KIYONO, H. & MCGHEE, J.R. (1999). Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. Infection and Immunity 67, 6249-56.
260. PASETTI, M.F., ANDERSON, R.J., NORIEGA, F.R., LEVINE, M.M. & SZTEIN, M.B. (1999). Attenuated δguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses. Clinical Immunology 92, 76-89.
261. PAUL, C., SHALALA, K., WARREN, R. & SMITH, R. (1985). Adoptive transfer of murine host protection to salmonellosis with T-cell growth factor-dependent, Salmonella-specific T-cell lines. Infection and Immunity 48, 40-3.
262. PFEIFER, J.D., WICK, M.J., ROBERTS, R.L., FINDLAY, K., NORMARK, S.J. & HARDING, C.V. (1993). Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361, 359-362.
263. PICKARD, D., LI, J., ROBERTS, M., MASKELL, D., HONE, D., LEVINE, M., DOUGAN, G. & CHATFIELD, S. (1994). Characterization of defined ompR mutants of Salmonella typhi: ompR is involved in the regulation of Vi polysaccharide expression. Infection and Immunity 62, 3984-93.
264. PISTOR, S. & HOBOM, G. (1990). OmpA-Haemagglutinin fusion proteins for oral immunization with live attenuated Salmonella. Research in Microbiology 141, 879-81.
265. POIRIER, T.P., KEHOE, M.A. & BEACHEY, E.H. (1988). Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein. Journal of Experimental Medicine 168, 25-32.
266. RAMARATHINAM, L., NIESEL, D.W. & KLIMPEL, G.R. (1993). Salmonella typhimurium induces IFN-gamma production in murine splenocytes. Role of natural killer cells and macrophages. Journal of Immunology 150, 3973-81.
267. REDMAN, T.K., HARMON, C.C., LALLONE, R.L. & MICHALEK, S.M. (1995). Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: dose response and induction of protective humoral responses in rats. Infection and Immunity 63, 2004-11.
268. RICHTER-DAHLFORS, A., BUCHAN, A.M.J. & FINLAY, B.B. (1997). Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo. Journal of Experimental Medicine 186, 569-80.
269. ROBERTS, M., CHATFIELD, S.N. & DOUGAN, G. (1994). In "Novel delivery system for oral vaccines" (O.H.D.T., ed.), pp. 27-58. CRC Press, Inc., Boca Raton, Fia.
270. ROBERTS, M., LI, J., BACON, A. & CHATFIELD, S. (1998). Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters [published erratum appears in Infect Immun 1999 Jan;67(1):468]. Infection and Immunity 66, 3080-7.
271. ROBERTSSON, J.A., FOSSUM, C., SVENSON, S.B. & LINDBERG, A.A. (1982a). Salmonella typhimurium infection in calves: specific immune reactivity against O-antigenic polysaccharide detectable in in vitro assays. Infection and Immunity 37, 728-36.
272. ROBERTSSON, J.A., LINDBERG, A.A., HOISETH, S. & STOCKER, B.A. (1983). Salmonella typhimurium infection in calves: protection and survival of virulent challenge bacteria after immunization with live or inactivated vaccines. Infection and Immunity 41, 742-50.
273. ROBERTSSON, J.A., SVENSON, S.B. & LINDBERG, A.A. (1982b). Salmonella typhimurium infection in calves: delayed specific skin reactions directed against the O-antigenic polysaccharide chain. Infection and Immunity 37, 737-48.
274. ROLAND, K., CURTISS, R.R. & SIZEMORE, D. (1999). Construction and evaluation of a Acya Acrp Salmonella typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens. Avian Disease 43, 429-41.
275. ROWLEY, D., AUZINS, I. & JENKIN, C.R. (1968). Further studies regarding the question of cellular immunity in mouse typhoid. Australian Journal of Experimental Biology and Medical Science 46, 447-63.
276. RUSSMANN, H., SHAMS, H., POBLETE, F., FU, Y., GALAN, J.E. & DONIS, R.O. (1998). Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 281, 565-8.
277. SADOFF, J.C., BALLOU, W.R., BARON, L.S., MAJARIAN, W.R., BREY, R.N., HOCKMEYER, W.T., YOUNG, J.F., CRYZ, S.J., OU, J. & LOWELL, G.H. (1988). Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. Science 240, 336-8.
278. SANCHIS, R., ABADIE, G. & PARDON, P. (1995). Subcutaneous and conjunctival vaccination with a live attenuated strain of Salmonella abortusovis: effect of gestation on serological response of ewes. Veterinary Research 26, 110-5.
279. SAXEN, H. & MAKELA, O. (1982). The protective capacity of immune sera in experimental mouse salmonellosis is mainly due to IgM antibodies. Immunology Letters 5, 267-72.
280. SAXEN, H., MAKELA, O. & SVENSON, S.B. (1984). Isotype of protective anti-Salmonella antibodies in experimental mouse salmonellosis. Infection and Immunity 44, 633-6.
281. SAXEN, H., REIMA, I. & MAKELA, P.H. (1987). Alternative complement pathway activation by Salmonella O polysaccharide as a virulence determinant in the mouse. Microbial Pathogenesis 2, 15-28.
282. SCHAFER, R. & EISENSTEIN, T.K. (1992). Natural killer cells mediate protection induced by a Salmonella aroA mutant. Infection and Immunity 60, 791-7.
283. SCHODEL, F. (1990). Oral vaccination using recombinant bacteria. Seminars in Immunology 2, 341-9.
284. SCHODEL, F., ENDERS, G., JUNG, M.C. & WILL, H. (1990a). Recognition of a hepatitis B virus nucleocapsid T-cell epitope expressed as a fusion protein with the subunit B of Escherichia coli heat labile enterotoxin in attenuated Salmonellae. Vaccine 8, 569-72.
285. SCHODEL, F., MILICH, D.R. & WILL, H. (1990b). Hepatitis B virus nucleocapsid/pre-S2 fusion proteins expressed in attenuated Salmonella for oral vaccination. Journal of Immunology 145, 4317-21.
286. SCHODEL, F. & WILL, H. (1990). Expression of hepatitis B virus antigens in attenuated Salmonellae for oral immunization. Research in Microbiology 141, 831-7.
287. SCHORR, J., KNAPP, B., HUNDT, E., KUPPER, H.A. & AMANN, E. (1991). Surface expression of malarial antigens in Salmonella typhimurium: induction of serum antibody response upon oral vaccination of mice. Vaccine 9, 675-81.
288. SEGALL, T. & LINDBERG, A.A. (1993). Oral vaccination of calves with an aromatic-dependent Salmonella dublin (O9,12) hybrid expressing O4,12 protects against S. dublin (O9,12) but not against Salmonella typhimurium (O4,5,12). Infection and Immunity 61, 1222-31.
289. SHEA, J.E., BEUZON, C.R., GLEESON, C., MUNDY, R. & HOLDEN, D.W. (1999). Influence of the Salmonella typhimurium pathogenicity island 2 type III secretion system on bacterial growth in the mouse. Infection and Immunity 67, 213-9.
290. SHEA, J.E., HENSEL, M., GLEESON, C. & HOLDEN, D.W. (1996). Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proceedings of the National Academy of Science U S A 93, 2593-7.
291. SHILOH, M.U., MACMICKING, J.D., NICHOLSON, S., BRAUSE, J.E., POTTER, S., MARINO, M., FANG, F., DINAUER, M. & NATHAN, C. (1999). Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 10, 29-38.
292. SHILOH, M.U., RUAN, J. & NATHAN, C. (1997). Evaluation of bacterial survival and phagocyte function with a fluorescence-based microplate assay. Infection and Immunity 65, 3193-8.
293. SIGWART, D.F., STOCKER, B.A. & CLEMENTS, J.D. (1989). Effect of a purA mutation on efficacy of Salmonella live-vaccine vectors. Infection and Immunity 57, 1858-61.
294. SILVA, E.N., SNOEYENBOS, G.H., WEINACK, O.M. & SMYSER, C.F. (1981). Studies on the use of 9R strain of Salmonella gallinarum as a vaccine in chickens. Avian Disease 25, 38-52.
295. + derivatives of the vaccine mutant gal E Ty21a strain of Salmonella typhi]. Boletin Medico del Hospital Infantil de Mexico 42, 234-9.
296. SIMONET, M., FORTINEAU, N., BERETTI, J.L. & BERCHE, P. (1994). Immunization with live aroA recombinant Salmonella typhimurium producing invasin inhibits intestinal translocation of Yersinia pseudotuberculosis. Infection and Immunity 62, 863-7.
297. SINGH, M., GANGULY, N.K., KUMAR, L. & VOHRA, H. (1999). Protective efficacy and immunogenicity of Viporin conjugate against Salmonella typhi. Microbiology Immunology 43, 535-42.
298. SINHA, K., MASTROENI, P., HARRISON, J., DE HORMAECHE, R.D. & HORMAECHE, C.E. (1997). Salmonella typhimurium aroA, htrA, and aroD htrA mutants cause progressive infections in athymic (nu/nu) BALB/c mice. Infection and Immunity 65, 1566-9.
299. SJOSTEDT, A., SANDSTROM, G. & TARNVIK, A. (1992). Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium. Infection and Immunity 60, 2855-62.
300. SKEEN, M.J. & ZIEGLER, H.K. (1993). Induction of murine peritoneal γ/δ T cells and their role in resistance to bacterial infection. Journal of Experimental Medicine 178, 971-84.
301. SMERDOU, C., ANTON, I.M., PLANA, J., CURTISS, R.R. & ENJUANES, L. (1996). A continuous epitope from transmissible gastroenteritis virus S protein fused to E. coli heat-labile toxin B subunit expressed by attenuated Salmonella induces serum and secretory immunity. Virus Research 41, 1-9.
302. SMITH, H.W. (1956). The use of live vaccines in experimental Salmonella gallinarum infection in chickens with observations on their interference effect. Journal of Hygiene, Cambridge 54, 419-32.
303. SMITH, B.P., DILLING, G.W., DA RODEN, L. & STOCKER, B.A. (1993). Vaccination of calves with orally administered aromatic-dependent Salmonella dublin. American Journal of Veterinary Research 54, 1249-55.
304. SMITH, B.P., REINA-GUERRA, M., HOISETH, S.K., STOCKER, B.A., HABASHA, F., JOHNSON, E. & MERRITT, F. (1984). Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves. American Journal of Veterinary Research 45, 59-66.
305. SOMERVILLE, J.E., JR, CASSIANO, L., BAINBRIDGE, B., CUNNINGHAM, M.D. & DARVEAU, R.P. (1996). A novel Escherichia coli lipid A mutant that produces an anti-inflammatory lipopolysaccharide. Journal of Clinical Investigation 97, 359-65.
306. SRINIVASAN, J., TINGE, S., WRIGHT, R., HERR, J.C. & CURTISS, R.R. (1995). Oral immunization with attenuated Salmonella expressing human sperm antigen induces antibodies in serum and the reproductive tract. Biology of Reproduction 53, 462-71.
307. STABEL, T.J., MAYFIELD, J.E., MORFITT, D.C. & WANNEMUEHLER, M.J. (1993). Oral immunization of mice and swine with an attenuated Salmonella choleraesuis [Δcya-12 Δ(crp-cdt) 19] mutant containing a recombinant plasmid. Infection and Immunity 61, 610-8.
308. STABEL, T.J., MAYFIELD, J.E., TABATABAI, L.B. & WANNEMUEHLER, M.J. (1990). Oral immunization of mice with attenuated Salmonella typhimurium containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus. Infection and Immunity 58, 2048-55.
309. STABEL, T.J., MAYFIELD, J.E., TABATABAI, L.B. & WANNEMUEHLER, M.J. (1991a). Swine immunity to an attenuated Salmonella typhimurium mutant containing a recombinant plasmid which codes for production of a 31 - kilodalton protein of Brucella abortus. Infection and Immunity 59, 2941-7.
310. STABEL, T.J., MAYFIELD, J.E., TABATABAI, L.B. & WANNEMUEHLER, M.J. (1991b). Swine immunity to an attenuated Salmonella typhimurium mutant containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus. Infection and Immunity 59, 2941-7.
311. STAGER, S., GOTTSTEIN, B. & MULLER, N. (1997). Systemic and local antibody response in mice induced by a recombinant peptide fragment from Giardia lamblia variant surface protein (VSP) H7 produced by a Salmonella typhimurium vaccine strain. International Journal of Parasitology 27, 965-71.
312. STEGER, K.K., VALENTINE, P.J., HEFFRON, F., SO, M. & PAUZA, C.D. (1999). Recombinant, attenuated Salmonella typhimurium stimulate lymphoproliferative responses to SIV capsid antigen in rhesus macaques. Vaccine 17, 923-32.
313. STOCKER, B.A. (1988). Auxotrophic Salmonella typhi as live vaccine. Vaccine 6, 141-5.
314. STOCKER, B.A. (1990). Aromatic-dependent Salmonella as live vaccine presenters of foreign epitopes as inserts in flagellin. Research in Microbiology 141, 787-96.
315. STRAHAN, K., CHATFIELD, S.N., TITE, J., DOUGAN, G. & HORMAECHE, C.E. (1992). Impaired resistance to infection does not increase the virulence of Salmonella htrA live vaccines for mice. Microbial Pathogenesis 12, 311-7.
316. STRUGNELL, R., DOUGAN, G., CHATFIELD, S., CHARLES, I., FAIRWEATHER, N., TITE, J., LI, J.L., BEESLEY, J. & ROBERTS, M. (1992). Characterization of a Salmonella typhimurium aro vaccine strain expressing the P. 69 antigen of Bardetella pertussis. Infection and Immunity 60, 3994-4002.
317. STRUGNELL, R.A., MASKELL, D., FAIRWEATHER, N., PICKARD, D., COCKAYNE, A., PENN, C. & DOUGAN, G. (1990). Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains. Gene 88, 57-63.
318. SU, G.F., BRAHMBHATT, H.N., WEHLAND, J., ROHDE, M. & TIMMIS, K.N. (1992). Construction of stable LamB-Shiga toxin B subunit hybrids: analysis of expression in Salmonella typhimurium aroA strains and stimulation of B subunit-specific mucosal and serum antibody responses. Infection and Immunity 60, 3345-59.
319. SVENSON, S.B. & LINDBERG, A.A. (1981). Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice. Infection and Immunity 32, 490-6.
320. SVENSON, S.B., NURMINEN, M. & LINDBERG, A.A. (1979). Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium. Infection and Immunity 25, 863-72.
321. SYDENHAM, M., DOUCE, G., BOWE, F., AHMED, S., CHATFIELD, S. & DOUGAN, G. (2000). Salmonella enterica serovar typhimurium surA mutants are attenuated and effective live oral vaccines. Infection and Immunity 68, 1109-15.
322. SZTEIN, M.B., TANNER, M.K., POLOTSKY, Y., ORENSTEIN, J.M. & LEVINE, M.M. (1995). Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans. Journal of Immunology 155, 3987-93.
323. SZTEIN, M.B., WASSERMAN, S.S., TACKET, C.O., EDELMAN, R., HONE, D., LINDBERG, A.A. & LEVINE, M.M. (1994). Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. Journal of Infectious Diseases 170, 1508-17.
324. SZU, S.C., LI, X.R., SCHNEERSON, R., VICKERS, J.H., BRYLA, D. & ROBBINS, J.B. (1989). Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi. Infection and Immunity 57, 3823-7.
325. SZU, S.C., STONE, A.L., ROBBINS, J.D., SCHNEERSON, R. & ROBBINS, J.B. (1987). Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals. Journal of Experimental Medicine 166, 1510-24.
326. TACKET, C.O., HONE, D.M., CURTISS, R.D., KELLY, S.M., LOSONSKY, G., GUERS, L., HARRIS, A.M., EDELMAN, R. & LEVINE, M.M. (1992a). Comparison of the safety and immunogenicity of AaroC AaroD and Δcya Δcrp Salmonella typhi strains in adult volunteers. Infection and Immunity 60, 536-41.
327. TACKET, C.O., HONE, D.M., LOSONSKY, G.A., GUERS, L., EDELMAN, R. & LEVINE, M.M. (1992b). Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain. Vaccine 10, 443-6.
328. TACKET, C.O., LOSONSKY, G., TAYLOR, D.N., BARON, L.S., KOPECKO, D., CRYZ, S. & LEVINE, M.M. (1991). Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies. Journal of Infections Diseases 163, 901-4.
329. TACKET, C.O., SZTEIN, M.B., LOSONSKY, G.A., WASSERMAN, S.S., NATARO, J.P., EDELMAN, R., PICKARD, D., DOUGAN, G., CHATFIELD, S.N. & LEVINE, M.M. (1997). Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infection and Immunity 65, 452-6.
330. TACKET, C.O., SZTEIN, M.B., WASSERMAN, S.S. LOSONSKY, G., KOTLOFF, K.L., WYANT, T.L., NATARO, J.P., EDELMAN, R., PERRY, J., BEDFORD, P., BROWN, D., CHATFIELD, S., DOUGAN, G. & LEVINE, M.M. (2000). Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers. Infection and Immunity 68, 1196-201.
331. TAGLIABUE, A., VILLA, L., DE MAGISTRIS, M.T., ROMANO, M., SILVESTRI, S., BORASCHI, D. & NENCIONT, L. (1986). IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine. Journal of Immunology 137, 1504-10.
332. TAYLOR, P.D., INCHLEY, C.J. & GALLAGHER, M.P. (1998). The Salmonella typhimurium AhpC polypeptide is not essential for virulence in BALB/c mice but is recognized as an antigen during infection. Infection and Immunity 66, 3208-17.
333. THATTE, J., RATH, S. & BAL, V. (1993). Immunization with live versus killed Salmonella typhimurium leads to the generation of an IFN-γ-dominant versus an IL-4-dominant immune response. International Immunology 5, 1431-6.
334. TIJHAAR, E.J., SIEBELINK, K.H., KARLAS, J.A., BURGER, M.C., MOOI, F.R. & OSTERHAUS, A.D. (1997). Induction of feline immunodeficiency virus specific antibodies in cats with an attenuated Salmonella strain expressing the Gag protein. Vaccine 15, 587-96.
335. TIJHAAR, E.J., ZHENG-XIN, Y., KARLAS, J.A., MEYER, T.F., STUKART, M.J., OSTERHAUS, A.D. & MOOI, E.R. (1994). Construction and evaluation of an expression vector allowing the stable expression of foreign antigens in a Salmonella typhimurium vaccine strain. Vaccine 12, 1004-11.
336. TITBALL, R.W., HOWELLS, A.M., OYSTON, P.C. & WILLIAMSON, E.D. (1997). Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague. Infection and Immunity 65, 1926-30.
337. TITE, J.P., DOUGAN, G. & CHATFIELD, S.N. (1991). The involvement of tumor necrosis factor in immunity to Salmonella infection. Journal of Immunology 147, 3161-4.
338. TURNER, S.J., CARBONE, F.R. & STRUGNELL, R.A. (1993). Salmonella typhimurium AaroA AaroD mutants expressing a foreign recombinant protein induce specific major histocompatibility complex class I-restricted cytotoxic T-lymphocytes in mice. Infection and Immunity 61, 5374-5380.
339. TZSCHASCHEL, B.D., GUZMAN, C.A., TIMMIS, K.N. & DE LORENZO, V. (1996). An Escherichia coli hemolysin transport system-based vector for the export of polypeptides: export of Shiga-like toxin IIeB subunit by Salmonella typhimurium aroA. Nature Biotechnology 14, 765-9.
340. UDHAYAKUMAR, V. & MUTHUKKARUPPAN, V.R. (1987). An outer membrane protein (porin) as an eliciting antigen for delayed-type hypersensitivity in murine salmonellosis. Infection and Immunity 55, 822-4.
341. UMEZAWA, K., AKAIKE, T., FUJII, S., SUGA, M., SETOGUCHI, K, OZAWA, A. & MAEDA, H. (1997). Induction of nitric oxide synthesis and xanthine oxidase and their roles in the antimicrobial mechanism against Salmonella typhimurium infection in mice. Infection and Immunity 65, 2932-40.
342. VALENTINE, P.J., MEYER, K., RIVERA, M.M., LIPPS, C., PAUZA, D., MAZIARZ, R.T., SO, M. & HEFFRON, F. (1996). Induction of SIV capsid-specific CTL and mucosal sIgA in mice immunized with a recombinant S. typhimurium aroA mutant. Vaccine 14, 138-46.
343. VAZQUEZ-TORRES, A., JONES-CARSON, J., BAUMLER, A.J., FALKOW, S., VALDIVIA, R., BROWN, W., LE, M., BERGGREN, R., PARKS, W.T. & FANG, F.C. (1999). Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 401, 804-8.
344. VAZQUEZ-TORRES, A. XU, Y., JONES-CARSON, J., Holden, D.W., LUCIA, S.M., DINAUER, M., MASTROENI, P. & FANG, F.C. (2000). Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 287, 1655-58.
345. VERMA, N.K, ZIEGLER, H.K, STOCKER, B.A. & SCHOOLNIK, G.K, (1995a). Induction of a cellular immune response to a defined T-cell epitope as an insert in the flagellin of a live vaccine strain of Salmonella. Vaccine 13, 235-44.
346. VERMA, N.K., ZIEGLER, H.K., WILSON, M., KHAN, M., SAFLEY, S., STOCKER, B.A. & SCHOOLNIK, G.K. (1995b). Delivery of class I and class II MHC-restricted T-cell epitopes of listeriolysin of Listeria monocytogenes by attenuated Salmonella. Vaccine 13, 142-50.
347. VIDAL, S.M., MALO, D., VOGAN, K., SKAMENE, E. & GROS, P. (1993). Natural resistance to infection with intracellular parasites: isolation of a candidate for Beg. Cell 73, 469-85.
348. VILLARREAL, B., MASTROENI, P., DE HORMAECHE, R.D. & HORMAECHE, C.E. (1992). Proliferative and T-cell specific interleukin (IL-2/IL-4) production responses in spleen cells from mice vaccinated with aroA live attenuated Salmonella vaccines. Microbial Pathogenesis 13, 305-15.
349. VILLARREAL-RAMOS, B., MANSER, J., COLLINS, R.A., DOUGAN, G., CHATFIELD, S.N. & HOWARD, C.J. (1998). Immune responses in calves immunised orally or subcutaneously with a live Salmonella typhimurium aro vaccine. Vaccine 16, 45-54.
350. VILLARREAL-RAMOS, B., MANSER, J.M., COLLINS, R.A., DOUGAN, G. & HOWARD, C.J. (2000). Cattle immune responses to tetanus toxoid elicited by recombinant S. typhimurium vaccines or tetanus toxoid in alum or Freund's adjuvant. Vaccine 18, 1515-1521.
351. VORDERMEIER, H.M. & KOTLARSKI, I. (1990a). Identification of antigens which stimulate T lymphocytes of Salmonella enteritidis 11RX immunized mice. Immunology and Cell Biology 68, 299-305.
352. VORDERMEIER, H.M. & KOTLARSKI, I. (1990b). Partial purification and characterization of low molecular weight antigens of Salmonella enteritidis 11RX. Immunology and Cell Biology 68, 307-16.
353. VORDERMEIER, H.M., POPE, M. & KOTLARSKI, I. (1990). Presentation of Salmonella antigens by peritoneal cells of normal and Salmonella-infected mice. Immunology and Cell Biology 68, 161-72.
354. VRTALA, S., GROTE, M., FERREIRA, F., SUSANI, M., STOCKER, B., KRAFT, D. & VALENTA, R. (1995). Humoral immune responses to recombinant tree pollen allergens (Bet v I and Bet v II) in mice: construction of a live oral allergy vaccine. International Archives of Allergy and Applied Immunology 107, 290-4.
355. WALKER, M.J., ROHDE, M., TIMMIS, K.N. & GUZMAN, C.A. (1992). Specific lung mucosal and systemic immune responses after oral immunization of mice with Salmonella typhimurium aroA, Salmonella typhi Ty21a, and invasive Escherichia coli expressing recombinant pertussis toxin S1 subunit. Infection and Immunity 60, 4260-8.
356. WANG, J., MICHEL, V., LECLERC, C., HOFNUNG, M. & CHARBIT, A. (1999). Immunogenicity of viral B-cell epitopes inserted into two surface loops of the Escherichia coli K12 LamB protein and expressed in an attenuated aroA strain of Salmonella typhimurium. Vaccine 17, 1-12.
357. WATSON, B.C., ROBBINS, J.B. & SZU, S.C. (1992). Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine. Infection and Immunity 60, 4679-86.
358. WEINTRAUB, B.C., ECKMANN, L., OKAMOTO, S., HENSE, M., HEDRICK, S.M. & FIERER, J. (1997). Role of αβ and γδ T cells in the host response to Salmonella infection as demonstrated in T-cell-receptor-deficient mice of defined Ity genotypes [published erratum appears in Infect Immun 1998 Feb;66(2):882]. Infection and Immunity 65, 2306-12.
359. WHITTLE, B.L., LEE, E., WEIR, R.C. & VERMA, N.K. (1997a). Immune response to a Murray Valley encephalitis virus epitope expressed in the flagellin of an attenuated strain of Salmonella. Journal of Medical Microbiology 46, 129-38.
360. WHITTLE, B.L., SMITH, R.M., MATTHAEI, K.I., YOUNG, I.G. & VERMA, N.K. (1997c). Enhancement of the specific mucosal IgA response in vivo by interleukin- 5 expressed by an attenuated strain of Salmonella serotype Dublin. Journal of Medical Microbiology 46, 1029-38.
361. WRAY, C., SOJKA, W.J., MORRIS, J.A. & BRINLEY MORGAN, W.J. (1977). The immunization of mice and calves with gal E mutants of Salmonella typhimurium. Journal of Hygiene (Lond) 79, 17-24.
362. WRAY, C., SOJKA, W.J., PRITCHARD, D.G. & MORRIS, J.A. (1983). Immunization of animals with gal E mutants of "Salmonella typhimurium". Developments in Biological Standardisation 53, 41-6.
363. WU, J.Y., NEWTON, S., JUDD, A., STOCKER, B. & ROBINSON, W.S. (1989). Expression of immunogenic epitopes of hepatitis B surface antigen with hybrid flagellin proteins by a vaccine strain of Salmonella. Proceedings of the National Academy of Science USA 86, 4726-30.
364. WU, S., PASCUAL, D.W., LEWIS, G.K. & HONE, D.M. (1997). Induction of mucosal and systemic responses against human immunodeficiency virus type 1 glycoprotein 120 in mice after oral immunization with a single dose of a Salmonella-HIV vector. AIDS Research and Human Retroviruses 13, 1187-94.
365. XU, D., MCSORLEY, S.J., CHATFIELD, S.N., DOUGAN, G. & LIEW, F.Y. (1995). Protection against Leishmania major infection in genetically susceptible BALB/c mice by gp63 delivered orally in attenuated Salmonella typhimurium (AroA AroD). Immunology 85, 1-7.
366. XU, D., MCSORLEY, S.J., TETLEY, L., CHATFIELD, S., DOUGAN, G., CHAN, W.L., SATOSKAR, A., DAVID, J.R. & LIEW, F.Y. (1998). Protective effect on Leishmania major infection of migration inhibitory factor, TNF-α, and IFN-γ administered orally via attenuated Salmonella typhimurium. Journal of Immunology 160, 1285-9.
367. XU, H.R., Hsu, H.S., MONCURE, C.W. & KING, R.A. (1993). Correlation of antibody titres induced by vaccination with protection in mouse typhoid. Vaccine 11, 725-9.
368. YAN, Z.X., REUSS, F. & MEYER, T.F. (1990). Construction of an invertible DNA segment for improved antigen expression by a hybrid Salmonella vaccine strain. Research in Microbiology 141, 1003-4.
369. YANG, D.M., FAIRWEATHER, N., BUTTON, L.L., MCMASTER, W.R., KAHL, L.P. & LIEW, F.Y. (1990). Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis. Journal of Immunology 145, 2281-5.
370. ZHANG-BARBER, L., TURNER, A.K., DOUGAN, G. & BARROW, P.A. (1998). Protection of chickens against experimental fowl typhoid using a nuoG mutant of Salmonella serotype Gallinarum. Vaccine 16, 899-903.